In an important research that could lead to the development of vaccine to prevent one of the most prevalent diseases of our time - Type-2 diabetes, US researchers have found that toxins produced by a bacterium may cause the disease.
An international research team led by Cesar A. Arias, M.D., Ph.D., at The University of Texas Health Science Center at Houston (UTHealth) has identified a new superbug that caused a bloodstream infection in a Brazilian patient.
In a breakthrough, scientists have discovered a new class of antibiotics to fight deadly bacteria such as methicillin-resistant Staphylococcus aureus and other drug-resistant bacteria that threaten public health.
Researchers have claimed that a toxin produced by the common bacteria Staphylococcus aureus -known as "staph" - causes immune-system cells in the skin to react in a way that produces eczema-like rashes.
In a new study, researchers have suggested that an existing HIV drug called maraviroc could be a potential therapy for Staphylococcus aureus - a notorious and deadly pathogen linked to hundreds of thousands of hospitalizations each year.